Coronary artery disease (CAD) is the most common cause of death globally. In CAD, plaques composed of cholesterol, fats, calcium and other compounds accumulate and create obstructions in the coronary ...
Background: Coronary calcium scoring (CCS) evaluates atherosclerotic burden and cardiovascular risk, correlating with coronary artery disease (CAD) severity. Advances in Nuclear Magnetic Resonance (1 ...
AutoChamber™ and AutoBMD™ AI solutions will soon be available on Precision Imaging Network, with AI-CVD® planned next.
Integrating male sex, RBBB, and haemoglobin and glucose levels into the HEART score improves its ability to predict significant coronary artery disease on CCTA in the emergency department setting.
Advanced Photon-Counting Computed Tomography (PCCT) has demonstrated a 100% diagnostic quality and revealed that 74% of ...
Abstract: With the growing global threat of coronary artery disease (CAD), automated CAD diagnosis techniques based on coronary CT angiography (CCTA) have been developed. However, their clinical ...
Background Coronary microvascular dysfunction (CMD) is associated with a poor prognosis but is difficult to diagnose non-invasively. In a recent paper, ST-segment depression on exercise-ECG was found ...
Many people identified as low risk for cardiovascular disease by standard risk calculators go on to have a heart attack, ...
There is an emerging convergence between atherosclerotic cardiovascular disease and cancer, driven by shared risk factors and overlapping pathophysiologic mechanisms. Traditional factors, such as ...
Award-winning presentation recognizes AI-CVD-HF heart failure prediction model leveraging coronary artery calcium (CAC) scans HONG KONG, January 27, 2026 /EINPresswire.com/ — HeartLung AI announced ...
MURRAY, Utah (ABC4 Utah) – Coronary artery calcium (CAC) CT scans are becoming a more commonly used tool to effectively determine a patient’s future risk of heart disease and heart attack. These ...
Background Patients with prior coronary artery bypass grafting (CABG) account for around 10% of non-ST-elevation acute coronary syndromes (NSTE-ACS), but the optimal diagnostic and management strategy ...